Teva Pharmaceutical Industries Ltd ADR buy JPMorgan Chase & Co.
Start price
12.05.25
/
50%
€15.60
Target price
12.05.26
€20.49
Performance (%)
62.82%
Price
12.12.25
€25.40
Summary
This prediction is currently active. With a performance of 62.82% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 12.05.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 3.673% | 3.673% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $23.00 price target on the stock, up previously from $21.00.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€21.40
06.11.25
06.11.25
€24.33
06.11.26
06.11.26
18.69%
12.12.25
12.12.25
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€17.10
03.10.25
03.10.25
€22.18
03.10.26
03.10.26
48.54%
12.12.25
12.12.25